Managing presenting problems with benzodiazepines. By Dr Gideon Felton MRCPsych Consultant Psychiatrist and Clinical Lead

Similar documents
SCENARIOS IN SUBSTANCE MISUSE. By Dr Gideon Felton Consultant Psychiatrist and Clinical Lead

Managing presenting alcohol users an Introduction to SPECTRUM (CRI) By Dr Gideon Felton MRCPsych Consultant Psychiatrist and Clinical Lead

Managing Opiate prescribing and dispensing. By Dr Gideon Felton MRCPsych Consultant Psychiatrist and Clinical Lead

Benzodiazepines: Comparative Effectiveness and Strategies for Discontinuation. Ann M. Hamer, PharmD, BCPP Rural Oregon Academic Detailing Project

Using Benzodiazepines in Primary Care

Basics of Benzodiazepine Use Disorder. DATE: October 3, 2017 PRESENTED BY: Melissa B. Weimer, DO, MCR

Basics of Benzodiazepine Use Disorder. DATE: March 20, 2018 PRESENTED BY: Melissa B. Weimer, DO, MCR

Basics of Benzodiazepine Use Disorder. DATE: June 12, 2018 PRESENTED BY: Melissa B. Weimer, DO, MCR

Anxiolytic and Hypnotic drugs

Benzodiazepines: risks, benefits or dependence

Anxiety Pharmacology UNIVERSITY OF HAWAI I HILO PRE -NURSING PROGRAM

Anxiolytic & Hypnotic Drugs. Asst Prof Dr Inam S Arif

11/1/2010. Psychology 472 Pharmacology of Psychoactive Drugs. Listen to the audio lecture while viewing these slides

WHEN AND HOW TO USE BENZODIAZEPINES IN TREATING ANXIETY: AM I WITHHOLDING TREATMENT IF I DON'T USE BENZODIAZEPINES?

Dr Chris Ford Clinical Director IDHDP (International Doctors for Healthy Drug Policies) Thursday 16 th May 2013

Friend or Foe? Review of the Regulations & Benefits: Risk Profiles of the Benzodiazepines

DRUG RELATED DEATHS AND PREGABALIN. Dr Abhishek Goli INSPIRE CGL

MEDICATION ALGORITHM FOR ANXIETY DISORDERS

Treating Anxiety Disorders. Adil Virani, BSc (Pharm), Pharm D, FCSHP

What is pregabalin? Pregabalin tablets. Pregabalin misuse. National Drug Treatment Centre Research. Administration

HOPE. Considerations. Considerations ISING. Safe Opioid Prescribing Guidelines for ACUTE Non-Malignant Pain

Anxiolytic, Sedative and Hypnotic Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

WHAT SHOULD WE DO ABOUT BENZODIAZEPINES? Miriam Komaromy, MD Associate Director, Project ECHO August 2014

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

SHARED CARE GUIDELINE FOR THE MANAGEMENT OF PATIENTS ON NALTREXONE FOR OPIOID DEPENDENCE

C AT E G O R Y I I I COMMUNICATION, TREATMENT & PREVENTION INTERVENTIONS PHARMACOLOGY OF ADDICTIONS

SUMMARY OF PRODUCT CHARACTERISTICS FOR BENZODIAZEPINES AS ANXIOLYTICS OR HYPNOTICS

SiGMA/ MMHSCT GUIDELINES FOR ANTIPSYCHOTIC DRUG TREATMENT OF SCHIZOPHRENIA. [compatible with NICE guidance]

Addictions in General Practice 16 th November 2017

BENZODIAZEPINES: WHAT YOU DON T KNOW CAN HURT YOU

Multiple Choice Questions

Main Questions. Why study addiction? Substance Use Disorders, Part 1 Alecia Schweinsburg, MA Abnromal Psychology, Fall Substance Use Disorders

1/20/2017. Benzodiazepines Overuse. Pharmacist Objectives. Technician Objectives. A Bit of History. Benzodiazepines: Mechanism of Action

Subject: Pain Management (Page 1 of 7)

Alcohol Use in the Elderly

Good evening doctors..

Patient Profile. Patient s details Initials: IF Age: 40 Gender: Male. Weight: 139.7kg Height: 510 metres BMI: >47

A guide to reducing or stopping mental health medication. Notes for prescribers

Scottish Blues- Benzodiazepines and Drug Related Deaths in Scotland

Emergency Control of the Acutely Disturbed Adult Patient GUIDELINES ON EMERGENCY CONTROL OF THE ACUTELY DISTURBED ADULT PATIENT... 2 ACTION...

Document Title Pharmacological Management of Generalised Anxiety Disorder

MEDICATION ASSISTED ADDICTION TREATMENT: Appropriate Use

Psychosis with coexisting substance misuse

Clonazepam temazepam clonazepam temazepam compared temazepam clonazepam klonopin temazepam Clonazepam vs Temazepam Clonazepam Temazepam Temazepam

Anxiety Disorders: First aid and when to refer on

DRUGS THAT ACT IN THE CNS

Soma (carisoprodol), Soma Compound (carisoprodol and aspirin), Soma Compound w/ Codeine (carisoprodol and aspirin and codeine)

Tranquilizers & Sedative-Hypnotics

Benzodiazepines. CRIT program May Alex Walley, MD, MSc Assistant Professor of Medicine Boston University School of Medicine

Substance Misuse in Older People

Soma (carisoprodol), Soma Compound (carisoprodol and aspirin), Soma Compound w/ Codeine (carisoprodol and aspirin and codeine)

Strategies in Managing Opioid and Benzodiazepine Co-Prescribing

Medication Management. Dr Ajith Weeraman MBBS, MD (Psychiatry), FRANZCP Consultant Psychiatrist Epworth Clinic Camberwell 14 th March 2015

Anxiety. Definition. Sometimes anxiety results from a medical condition that needs treatment. Whatever form of anxiety you have, treatment can help.

Drugs, Society and Behavior

Benzodiazepines. Benzodiazepines

Rationale & Strategy For Integrating Buprenorphine Treatment Into Community Health Centers

THEXANAX THREAT 1 THE XANAX THREAT. iaddiction.com

Who is at risk of misusing pharmaceuticals? Overdose in Victoria. But I don t have a drug problem 10/18/2018. Rates of opioid prescribing

Benzodiazepine abuse code

MINOR TRANQUILIZERS CHAPTER TWO : MINOR TRANQUILIZERS

Sedatives and Hypnotics. Ahmad Al-Tarifi. Zahra Khalil. Pharmacology. 1 P a g e

SHARED CARE GUIDELINE FOR THE MANAGEMENT OF PATIENTS ON NALTREXONE FOR ALCOHOL DEPENDENCE INDICATION

Alcohol xanax cross tolerance

BACKGROUND Measuring renal function :

Sedative-Hypnotics & the Treatment of Hypersomnia October 22, 2018 Pharm 9002 Mark Beenhakker, Pharmacology

ADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines

The fact that your asking your doctor for a drug like Valium by name is enough to raise alarms that your just drug seeking. People like...

Vistaril ( hydroxyzine ) is a non-addictive antihistamine medication. This drug is used to relieve the itching caused by allergies and to control the

C HAPTER 8 A NXIETY D ISORDERS IN P ATIENTS W ITH HIV/AIDS

Medication-Assisted Treatment. What Is It and Why Do We Use It?

This is because the situation is demystified and the element of fear of the unknown is eliminated.

Dr Laith M Abbas Al-Huseini M.B.Ch.B, M.Sc., M.Res., Ph.D.

Sedative-Hypnotics (Barbiturates) Dr Deny Susanti

Psychopharmacology in the Emergency Room. Michael D. Jibson, M.D., Ph.D. Professor of Psychiatry University of Michigan

DRUGS USED IN THE TREATMENT OF ADDICTION JOSEPH A. TRONCALE, MD FASAM RETREAT PREMIERE ADDICTION TREATMENT CENTERS

Safe Prescribing of Drugs with Potential for Misuse/Diversion

Proposed Revision to Med (i)

Psychopharmacology in the Emergency Room. Michael D. Jibson, M.D., Ph.D. Associate Professor of Psychiatry University of Michigan

PSYCHIATRIC MANAGEMENT IN PRIMARY CARE. Dr Fayyaz Khan MBBS, MRCPsych, MSc Consultant Psychiatrist (Locum) Mersey Care NHS Trust

BEHAVIOURAL SCREENING OF DRUGS HYPNOTICS/SEDATIVES

Pain and Addiction. Edward Jouney, DO Department of Psychiatry

Sedative / Hypnotics

Chapter 7. Depressants and Inhalants. Depressants & Inhalants. History: Before Barbiturates 10/1/2012

Treatment of drug dependence What you need to know

Bree Collaborative AMDG Opioid Prescribing Guidelines Workgroup. Opioid Prescribing Metrics - DRAFT

Risk and Benefit of the Concomitant Use of Benzodiazepines and Opiates

HA Corporate Scholarship Program:

DRIVING, DVLA, AND ADVISING PATIENTS: TOP TIPS

MMG003 GUIDELINES FOR THE USE OF HYPNOTICS FOR THE TREATMENT OF INSOMNIA

CDC Guideline for Prescribing Opioids for Chronic Pain. Centers for Disease Control and Prevention National Center for Injury Prevention and Control

Anxiolytics. Benzodiazepines relieve anxiety for three reasons: Antipunishment effect Relief of anxiety symptoms. General sedation

SEDATIVE-HYPNOTICS. Mr. D.Raju, M.pharm, Lecturer

VALIUM LEGAL IN JAPAN

PROCEDURE REF NO SABP/EXECUTIVE BOARD/0017

Prescription Opioid Addiction

Intro to Concurrent Disorders

Opioids Research to Practice

Medication management of anxiety & depression. Dr Katie Simpson GP Mental health lead East Berks CCG

GUIDELINES FOR THE USE OF BENZODIAZEPINES IN OFFICE PRACTICE IN THE STATE OF MAINE

Transcription:

Managing presenting problems with benzodiazepines By Dr Gideon Felton MRCPsych Consultant Psychiatrist and Clinical Lead

OUTLINE OF PRESENTATION Why Benzodiazepines (BDZ s) are used Mechanism of Action Uses of BDZ Adverse effects of BDZ use Outline of Common BDZ s in use Management of the Adverse effects of BDZ use

EXCLUSION CRITERIA Presentation restricted to psychiatric use of BDZ only. Reduction driven by recovery agenda A patient may not be reduced if directed by another medical specialist. In this case, CRI will liaise with the appropriate specialist involved.

WHY Benzodiazepines increasingly replaced barbiturates as hypnotic of choice which led to widespread usage across all specialties. Less toxic than barbiturates in overdose so high doses given Well tolerated Easy available from legal and illicit sources ( 3-8 per 5mg tablet)

Mechanism of Action Potentiate the action of GABA-a receptors which opens Chloride channels, resulting in hyperpolarisation(making cell more negative) so that it is much harder for cell to generate action potential Barbiturates prolonged GABA action which was more dangerous

More MOA GABA( inhibitory) in balance with Glutamate(excitatory) GABA-b inhibits Glutamate as opposed to hyperpolarisation E.g. Pregabalin

Therapeutic uses of BDZ s Anxiolytic Sedative Muscle relaxant Anti-epileptic Prophylaxis against Delirium Tremens

Dangers of BDZ use Additively toxic when combined with Opiates and alcohol (re Sid Vicious)-potentiates respiratory depression+++ Tolerance inducing-made worse by ability to raise doses Discontinuation symptoms

Discontinuation symptoms Rebound symptoms Return of original symptoms that the BDZ was prescribed to treat. E.g. Insomnia, anxiety, raised seizure threshold, muscle cramps Withdrawal symptoms Previously unseen symptoms which appear after BDZ stopped

Withdrawal Symptoms Increased anxiety Depression Agitation Psychosis Depersonalisation Derealisation Formication

Discontinuation symptoms risk factors Marked in elderly due to poorer renal/hepatic clearance Worse in co-morbid addictions due to marked increase in inhibitory neurotransmitter involvement Worse if higher starting dose and/or length of time on script

Appropriate psychiatric use of BDZ Short term anxiolytic in treatment of panic disorder +/- agoraphobia, GAD, PTSD etc Ward based tranquilisation Alcohol detox both planned and medical Addiction probability increases if > 1/12 use

THE PROBLEMS TOLERANCE the more drug prescribed, the greater the number of receptors created, leading to unsatisfied receptors WITHDRAWAL SYMPTOMS-Insufficient quantity of drug to satisfy number of receptors

OTHER PROBLEMS INTOXICATION describes altered behaviour secondary to drug E.g. Altered gait, dizziness, poor coordination. ADDICTION is pt s behaviour in acquiring drug to stave off withdrawals-ie how the prime focus of the patient s day is the acquisition of drug

ADDICTIVE POTENTIAL Shorter acting and higher potency raises addiction potential as withdrawals most noticeable Longer acting is less addictive

LIST OF COMMONLY USED BDZ s Clonazepam Lorazepam Chlordiazepoxide (Librium) Temazepam Oxazepam Diazepam

PARTICULAR BDZ s Clonazepam-Treats agitated patients in secure settings Lorazepam-used on Ward for Rapid Tranquilisation-Very addictive and shorter acting Chlordiazepoxide(librium) Treats alcohol dependence and DT prophylaxis Oxazepam-Most renally cleared so useful if liver ds

MORE BDZ s Temazepam- hypnotic, shorter t1/2(12-48hrs) and more addictive Diazepam- Most available.long t1/2 (2/7-7/7), longer acting, least addictive. Comes in small preparations 10,5,2mg tablets

AIM To get patient from the more addictive BDZ to the lesser addictive one ALL ROADS LEAD TO DIAZEPAM!! Aim is to get BDZ addicted patient on a stable dose of diazepam and instigate a reduction from that point.

CONVERSION TO DIAZEPAM 10mg of diazepam = 1mg of lorazepam 0.5 mg of clonazepam 30mg of chlordiazepoxide 10mg of Temazepam

MANAGEMENT OF BDZ ADDICTION Get pt on stable dose of diazepam Reduce dose by 10% every 10-14 days Psycho-social interventions have a significant prognostic effect on the reduction Explain the need for reduction as Harm Minimisation agenda superseded. Major challenges are the many different and sometimes iatrogenic routes into addiction

NON BDZ ALTERNATIVES Trazadone anxiolytic antidepressant, particularly useful in elderly,nursing homes Pregabalin longer acting anxiolytic + massive dose range 25-600mg per day -Expensive, needs slow reduction plan Antipsychotic prescribing is off-label

HOW TO MANAGE A BDZ SCRIPT Always confirm that they are on a script if possible Do a urine test to see if pt actually dependent Get them on diazepam and reduce

MULTIPLE ADDICTIONS If a patient is on a methadone and diazepam script, take a rounded view of patient in terms of his motivation. If patient very motivated and positively engaged then you may try and reduce both substances. More caution is needed for BDZ reduction as withdrawals more severe

Scenario 1 33 yo new patient, on a diazepam script of 40mg from previous GP practice-you obtain evidence from old GP letters. You are not happy with this dose but patient insistent.

SOLUTION 1 Explain the need to reduce in terms of recovery ethos. Give patient initial script for 2 weeks only and then explain that he will be reduced at a rate of 10% every 2-3 weeks. Refer for psychosocial work Aim that next script will be at 36mg.

Scenario 2 You try reducing to 36mg, patient then comes in for a new script and states that he can t cope and used illicit diazepam this morning-he describes irritability and anxiety. What are your treatment options?

SOLUTION 2 If he used today, then script him from the next day. Start at 39mg and explain that the next script in 2/52 time will be 36 mg. Explain the need for engaging in recovery work.reinforce recovery agenda.

Scenario 3 The same patient receives his 2 weekly script of 36mg diazepam. He rings in 1 week later demanding to see a Dr stating that he has used all his diazepam as he heard bad news and he could not cope. What are the options?

SOLUTION 3 Dangerous scenario-patient could be trading medications and should not be given large take outs. Establish other drug/etoh use Rescripting will create problems in the future After KW feedback on attendance, explore coping strategies

SOLUTION 3 (cont) Try and establish what the triggers for each extra usage eg was it worse in evening Can refer to CMHT for specialised psychological therapies-possible medical management Cannot stop scripting but I would reinstate script in 4 days time at 36mg. Give 3 day scripts to stop diverting- Consider daily pick up

Scenario 4 A patient who was recently admitted to a psychiatric ward following a crisis and discharged after 3 days over the weekend. He was given 1 weeks worth of lorazepam at 1mg tds and has no CMHT follow up. He attends your practice requesting more lorazepam.

SOLUTION 4 Lorazepam very addictive. Work out that he has had 3mg lorazepam daily Equivalent to 30mg diazepam Get patient on 30mg diazepam script Consider daily pick up Weekly scripting Refer for psychosocial recovery work.

Scenario 5 A patient who is alcohol dependent was recently admitted to General Hospital following a chest infection. Whilst in hospital he was placed on a librium detox starting at 120mg in divided doses. His infection resolves in 4 days and he is discharged and is given librium 20mg qds as a take out script for 4 days He attends wanting continuation

SOLUTION 5 Dangerous practice as librium needs to be reduced However patient only been on short course Pt less likely to develop DT s Hospital admission deemed not necessary Possible to do home detox by reducing librium at a rate of 10mg reduction per day in 4 divided doses

Scenario 6 Same scenario as above but patient given librium 20mg qds take out for 2 weeks Patient attends requesting further continuation at this dose

SOLUTION 6 More common than expected Dangerous practice as patient has a new iatrogenic addiction! Too late for librium detox Convert to diazepam (3:1) ratio Thus 80mg librium is equivalent to approximately 27mg diazepam. Put in bd divided doses and reduce by 10%

Scenario 7 A recently referred patient has a neurological disorder but discharged by neurology team on 30 mg diazepam daily and 60 mg DH Codeine qds. You speak to the neurologist who confirms that there is no medical reason for these high doses. How do you proceed

SOLUTION 7 Patient has 2 addictions. Reducing the diazepam is the more difficult The Codeine can be managed like any other opiate Engaging in recovery work essential for psycho-social interventions Health psychology for CBT an option

Scenario 8 A patient has been recently discharged from a private practice who are no longer willing to prescribe his 60mg daily dose of diazepam. You are also very unwilling to script him at this level What are your treatment options

SOLUTION 8 60mg is high!! Patient must be informed that this dosage cannot be maintained Options are to start at 45mg diazepam and use adjunctive therapy with anti-depressant Pt needs referral into CMHT to manage underlying psychiatric cause Psychological therapies needed

SCENARIO 9 A 42 yo M attends the shared care surgery prescribed Methadone 45mls od and diazepam 20mg od. He admits to using more cocaine and is asking for an increase in both his methadone and diazepam as he is more anxious and is using both illicitly acquired heroin and diazepam. You dont want to increase any of these as you are nervous about toxicity

Solution 9 You need to consider transferring to CRI. He needs acute psychosocial interventions to address his cocaine use and short scripts to encourage engagement. You can consider adjunctive anti-depressant therapy (TCI s) if an underlying depression suspected as there is weak evidence for this. CRI dr will try and explore effect of each drug.

SCENARIO 10 48F arrives after being on clonazepam 1mg qds which she was prescribed overseas.

SOLUTION 10 Although 4mg clonazepam equates to 80mg diazepam, often starting at 50mg with sedative antidepressant can be effective. Eg starting trazodone at 150mg alongside the diazepam and uptitrating the trazodone rather than the diazepam

SCENARIO 11 A 33 yo F self reports using 60 mg of internet acquired diazepam for the last 3/12. You don t want to continue this. She c/o anxiety and states that she gets shakes every time she tries to self reduce.

SOLUTION Don t start the diazepam dose too high as it is better to under-dose and titrate upwards Set a top limit of 30mg with the option of going up to 40mg in very small titration increases.